Table 2.

CHOP-R-ESC trials—age groups patients 61–80 years (n = 561) demographics

	61–65 years	66–70 years	71–75 years	76–80 years
	n = 149	n = 188	n = 141	n = 83
Male	94 (63%)	103 (55%)	74 (52%)	32 (39%)
Female	55 (37%)	85 (45%)	67 (48%)	51 (61%)
Age, median (range)	63 (61, 65)	68 (66, 70)	73 (71, 75)	77 (76, 80)
LDH > UNV	78 (52%)	99 (53%)	73 (52%)	47 (57%)
ECOG > 1	12 (8%)	25 (13%)	17 (12%)	16 (19%)
Stage III/ IV	95 (64%)	112 (60%)	84 (60%)	52 (63%)
Extranod. involvement > 1	48 (32%)	57 (30%)	42 (30%)	23 (28%)
IPI 1	37 (25%)	47 (25%)	36 (26%)	16 (19%)
2	32 (22%)	45 (24%)	34 (24%)	24 (29%)
3	49 (33%)	51 (27%)	40 (28%)	20 (24%)
4, 5	31 (21%)	45 (24%)	31 (22%)	23 (28%)
Extranod. involvem.	99 (66%)	123 (65%)	99 (70%)	47 (57%)
Bulky disease	52 (35%)	67 (36%)	52 (37%)	31 (37%)
B symptoms	42 (28%)	63 (34%)	41 (29%)	21 (25%)
BM involvement	13 (9%)	17 (9%)	13 (9%)	3 (4%)